Sarepta Therapeutics Inc (SRPT): Company Short-Term Debts

SRPT (Sarepta Therapeutics) - company brandmark

This price chart for Sarepta Therapeutics, Inc. (SRPT) demonstrates the company's dynamics, where the indicator stands at 0.09. The business focuses on developing gene therapies for rare muscle pathologies, mitigating risks through global alliances and an extensive research portfolio. The firm generates revenue from high-cost therapy courses for individuals with genetic disorders. Its monopoly position is secured by FDA approval and colossal R&D expenditures.

SRPT sarepta.com Company Short-Term Loans and Borrowings (07/04/2022 - 11/01/2026)

Comprehensive metric breakdowns and analytics for Sarepta Corp (SRPT)

- current quotes and average value forecast:
Price Chart Sarepta|SRPT - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Sarepta Therapeutics|SRPT - Enterprise Value
- business book valuation details:
Net Assets per Single Share Sarepta|SRPT - Accounting Value of Company|Market Capitalization to Book Value Ratio sarepta.com|SRPT - Company Assets
- debt level and financial liquidity data:
Debt to Equity Sarepta Therapeutics, Inc.|SRPT - Long-Term Liabilities to Equity|Short-Term Debt to Equity Ratio Sarepta Therapeutics, Inc.|SRPT - Company Cumulative Indebtedness|Debts to Book Capitalization Sarepta Therapeutics|SRPT - Company Long-Term Debts|Company Current Liabilities Sarepta|Quick Liquidity Indicator sarepta.com
- earnings and multiples data:
SRPT - Profit After Payment of Taxes
Summary company analytics:Sarepta (SRPT)
Mass-produced product of sarepta.com

Investors are assessing the financial stability of Sarepta Therapeutics, Inc. (SRPT) through liquidity analysis. This indicator measures the total amount of all credit obligations maturing within one year. The trend in short-term liabilities on GURU.Markets allows for tracking the speed of debt service. For a company with absolute pricing power and inelastic demand, such payments are not critical. A low debt load confirms the fundamental stability of the business.

Competitors of Sarepta Therapeutics, Inc. (SRPT)

TEM - Company Short-Term Debt|Short-Term Debt Volume Qiagen NV QGEN|IONS: Company Short-Term Debts|Repligen Inc. (RGEN) - Company Short-Term Debts|Company Short-Term Debt Avidity Biosciences|CRSP: Company Short-Term Loans and Borrowings|Company Short-Term Debts WGS|RARE - Short-Term Debt|Company Short-Term Debt Beam Therapeutics Corp BEAM|TWST (Twist Bioscience Corp) - Current Liabilities|TXG: Company Current Liabilities|intelliatx.com - Amount of Current Liabilities|STOK: Company Short-Term Debts|BioLife Solutions Inc (BLFS) - Company Short-Term Debts|Company Current Liabilities WVE|MAZE: Company Short-Term Loans and Borrowings|Company Current Liabilities SION (Sionna Therapeutics Inc)|Amount of Current Liabilities PRME|Company Short-Term Debts TSHA (Taysha Gene Therapies, Inc.)|Company Short-Term Loans and Borrowings QURE|MeiraGTx PLC - Company Short-Term Debts|Short-Term Debt REGENXBIO Corp|Solid Biosciences Inc. (SLDB) - Company Short-Term Debt|ocugen.com - Company Short-Term Loans and Borrowings|PACB (PacBio) - Company Short-Term Debts|Company Short-Term Debts Benitec Biopharma Inc|Company Short-Term Debt Design Pharma (DSGN)|RCKT: Current Liabilities|Company Short-Term Debts FDMT (4D Molecular Therapeutics)|Lexeo Therapeutics Inc. (LXEO) - Short-Term Debt|KRRO: Company Current Liabilities|EDIT - Company Short-Term Debts|SLN (Silence Therapeutics Inc.) - Company Current Liabilities|PRQR: Amount of Current Liabilities|CDXS (Codexis Inc) - Company Short-Term Debts|sangamo.com (SGMO) - Short-Term Debt Volume|Company Short-Term Debts NAUT|Company Current Liabilities Metagenomi Inc. MGX|Company Short-Term Debt Precision BioSciences DTIL|Short-Term Debt Volume Generation Bio Co (GBIO)|BOLD: Company Current Liabilities|Company Short-Term Loans and Borrowings XCUR (Exicure, Inc.)|IMNN: Company Short-Term Debts|PHIO - Short-Term Debt Volume|Company Short-Term Debt Mustang Bio Inc|Company Short-Term Indebtedness RNAZ (TransCode)|Company Short-Term Debts BNGO|Company Current Liabilities adnas.com APDN|bluebird bio - Company Current Liabilities|Short-Term Debt Volume ImmunoPrecise Antibodies Ltd (IPA)|OMGA - Company Short-Term Debt|Short-Term Debt Volume Singular Genomics Corp OMIC|Regulus Therapeutics (RGLS) - Company Short-Term Debt|syros.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt Telesis Bio|TRACON Pharmaceuticals Inc. - Current Liabilities|Company Current Liabilities UBX (Unity Bio)